Atadja, Peter
Novartis Institutes for BioMedical Research,
China
2024 Rank: 64576
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2687 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64576 | 72772 |
| Total Cites | 12975 | 14205 |
| H-index | 63 | 64 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 406 | 416 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 978 | 1054 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 1852 | 1942 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9554 | 10139 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.40 |
| Self-Citation Percentage |
8.66%
|
|
Atadja, Peter
Novartis Institutes for BioMedical Research,
China
2023 Rank: 62148
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2632 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 62148 | 69089 |
| Total Cites | 12339 | 13552 |
| H-index | 61 | 64 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 390 | 400 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 952 | 1028 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 1782 | 1872 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9034 | 9604 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.41 |
| Self-Citation Percentage |
8.95%
|
|
Atadja, Peter
Novartis Institutes for BioMedical Research,
China
2022 Rank: 59180
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2515 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 59180 | 65761 |
| Total Cites | 11553 | 12738 |
| H-index | 59 | 62 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 366 | 376 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 917 | 993 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 1698 | 1788 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8404 | 8953 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.42 |
| Self-Citation Percentage |
9.30%
|
|
Atadja, Peter
China Novartis Institutes for BioMedical Research,
China
2021 Rank: 57086
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2444 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57086 | 63770 |
| Total Cites | 11081 | 12245 |
| H-index | 59 | 62 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 353 | 363 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 898 | 972 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 1643 | 1729 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8063 | 8598 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.42 |
| Self-Citation Percentage |
9.51%
|
|
Atadja, Peter
Novartis Institutes for BioMedical Research,
China
2020 Rank: 55165
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2464 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 55165 | 61037 |
| Total Cites | 10151 | 11283 |
| H-index | 56 | 60 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 321 | 331 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 858 | 932 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 1539 | 1625 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7315 | 7824 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.44 |
| Self-Citation Percentage |
10.03%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.